A Multiple Instance Learning framework that treats each patient as a bag of macrophage embeddings derived from a single-cell RNA foundation model shows the potential of MIL to uncover predictive and mechanistically interpretable immune states.
Abstract
Predicting immunotherapy response from single-cell data remains difficult due to patient-level labels, extreme class imbalance, and highly heterogeneous macrophage states. We present a Multiple Instance Learning (MIL) framework that treats each patient as a bag of macrophage embeddings derived from a single-cell RNA foundation model. The architecture incorporates an attention-based pooling mechanism with reduced model complexity, dropout-enhanced regularization and explicit attention penalties to improve stability in small-sample regimes. To address imbalanced clinical datasets, MIL outputs are optimized with a combined focal loss and supervised contrastive objective that simultaneously sharpens class boundaries and improves representation clustering. Across three cancer datasets, this approach outperforms pseudobulk aggregation, embedding baselines and standard MIL variants. Attention-weighted attribution and transcriptional regulatory analysis reveal distinct macrophage programs, interferon and antigen-presentation networks in responders versus hypoxia-linked regulatory modules in non-responders. This shows the potential of MIL to uncover predictive and mechanistically interpretable immune states.
The proposed Conserved Immune Topology (CIT) is a lightweight spatial representation for cross-cancer MSI-H prediction that augments foundation-model embeddings with biologically motivated immune descriptors, supporting cross-cancer generalization of pathology foundation models.
Cooperative Modular Representation Learning (CMRL), an uncertainty-gated multimodal framework that dynamically regulates inter-modality information flow based on sample-level epistemic uncertainty estimated via Evidential Deep Learning (EDL), is presented.
Sundus M. Jasim, Nabil Hezil, A. Bouridane et al.· bioRxiv· 0 citations
Robustness analysis revealed that predictive performance plateaued for some therapies with increasing training cohorts but continued to improve for others, suggesting inherent limits of supervised brute-force learning for certain treatments, but additional data and deeper mechanistic modeling may further enhance transc...
L. Pal, E. Gertz, N. Nair et al.· Cancer Research· 0 citations
An AI-driven multi-omics model using GDSC, CCLE, DepMap, CTRP, and TCGA data, integrating mutation, copy-number variation, RNA expression, DNA methylation, drug SMILES, and IC50/AUC responses is developed, demonstrating that multi-omics fusion and drug-structure modeling improve prediction stability and support interpr...
Xin-Yuan Kang, Ai-Lin Deng· Applied and Computational En...· 0 citations
TMEDRP is a novel two-stage learning framework that integrates tumor-intrinsic signatures and TME-specific components for enhanced clinical drug response prediction and exhibits promising zero-shot generalization across unseen cancer lineages and novel compounds, suggesting its robustness across diverse scenarios.
Ya-Bin Kuang, Hao-Chen Zhao, Yi Luo et al.· Bioinformatics· 0 citations
The effectiveness of immune checkpoint inhibitors (ICIs) heavily depends on the complex spatial interactions of cells within the tumor microenvironment (TME). However, existing predictive biomarkers generally lack spatial resolution and interpretability, making it difficult to guide clinical decisions or reveal actiona...
Gang Liu, Jia Wang, Jia Zhu· Intelligent & Human Futu...· 4 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.